Search Results - "Vass, Sylvie"

Duration of Androgen Deprivation Therapy in High-risk Prostate Cancer: A Randomized Phase III Trial by Nabid, Abdenour, Carrier, Nathalie, Martin, André-Guy, Bahary, Jean-Paul, Lemaire, Céline, Vass, Sylvie, Bahoric, Boris, Archambault, Robert, Vincent, François, Bettahar, Redouane, Duclos, Marie, Garant, Marie-Pierre, Souhami, Luis

“…Long-term androgen deprivation therapy (ADT) combined with radiotherapy (RT) is a standard treatment for patients with localized high-risk prostate cancer…”
Get full text

Randomized Trial of Antioxidant Vitamins to Prevent Acute Adverse Effects of Radiation Therapy in Head and Neck Cancer Patients by BAIRATI, Isabelle, MEYER, Francois, VIGNEAULT, Eric, VASS, Sylvie, DEL VECCHIO, Pierre, ROY, Jean, GELINAS, Michel, FORTIN, André, NABID, Abdenour, BROCHET, Francois, MERCIER, Jean-Philippe, TETU, Bernard, HAREL, Francois, ABDOUS, Belkacem

“…Many cancer patients take antioxidant vitamin supplements with the hope of improving the outcome of conventional therapies and of reducing the adverse effects…”
Get full text

Weight variation during androgen deprivation therapy in patients with localized prostate cancer: Data from two prospective randomized trials by Nabid, Abdenour, Carrier, Nathalie, Vigneault, Eric, Martin, André-Guy, Nguyen-Huynh, Thu-Van, Bahary, Jean-Paul, Vavassis, Peter, Bahoric, Boris, Brassard, Marc-Andre, Vass, Sylvie, Archambault, Robert, Vincent, Francois, Bettahar, Redouane, Duclos, Marie, Wilke, Derek R, Souhami, Luis

“…296 Background: In prostate cancer (PCa) treated with androgen deprivation therapy (ADT) and radiotherapy (RT), limited prospective data exist regarding weight…”
Get full text

43 Does Testosterone Recovery After Androgen Deprivation Therapy Impact on Overall Survival in Patients Cured from Prostate Cancer? Long-Term Prospective Data by Nabid, Abdenour, Carrier, Nathalie, Vigneault, Eric, Martin, André-Guy, Nguyen, Thu Van, Bahary, Jean-Paul, Vavassis, Peter, Bahoric, Boris, Brassard, Marc-André, Vass, Sylvie, Archambault, Robert, Vincent, François, Bettahar, Redouane, Duclos, Marie, Wilke, Derek, Souhami, Luis

Get full text

Should Adjuvant Radiation Therapy Be Systematically Proposed for Male Breast Cancer? A Systematic Review by Jardel, Pauline, Vignot, Stéphane, Cutuli, Bruno, Creisson, Anne, Vass, Sylvie, Barranger, Emmanuel, Thariat, Juliette

“…Guidelines for radiotherapy in male breast cancer (MBC) are lacking. Some extrapolate the results from female breast cancer trials, while others advocate…”
Get full text

425: Comparison of death rate from cardiovascular disease: prostate cancer patients vs general population by Nabid, Abdenour, Carrier, Nathalie, Martin, André-Guy, Bahoric, Boris, Wilke, Derek, Vigneault, Eric, Vincent, François, Bahary, Jean-Paul, Brassard, Marc-André, Duclos, Marie, Vavassis, Peter, Bettahar, Redouane, Archambault, Robert, Vass, Sylvie, Nguyen, Thu-Van, Souhami, Luis

Get full text

Testosterone recovery after androgen deprivation therapy in localised prostate cancer: Long-term data from two randomised trials by Nabid, Abdenour, Carrier, Nathalie, Vigneault, Eric, Martin, André-Guy, Bahary, Jean-Paul, Van Nguyen, Thu, Vavassis, Peter, Vass, Sylvie, Brassard, Marc-André, Bahoric, Boris, Archambault, Robert, Vincent, François, Bettahar, Redouane, Duclos, Marie, Wilke, Derek, Souhami, Luis

“…•Prospective data in intermediate and high-risk prostate cancer.•Testosterone measurements per protocol, initially and at each visit.•Different durations of…”
Get full text

109: Prostate Cancer-Specific Death Rates in Localized Prostate Cancer: Data from Two Randomized Trials by Nabid, Abdenour, Carrier, Nathalie, Vigneault, Eric, Vavassis, Peter, Brassard, Marc-André, Bahoric, Boris, Archambault, Robert, Vincent, François, Bettahar, Redouane, Wilke, Derek, Van Nguyen, Thu, Martin, André-Guy, Bahary, Jean-Paul, Duclos, Marie, Vass, Sylvie, Souhami, Luis

Get full text

Duration of androgen deprivation therapy in high risk prostate cancer: Final results of a randomized phase III trial by Nabid, Abdenour, Garant, Marie-Pierre, Martin, André-Guy, Bahary, Jean-Paul, Lemaire, Celine, Vass, Sylvie, Bahoric, Boris, Archambault, Robert, Vincent, Francois, Bettahar, Redouane, Carrier, Nathalie, Duclos, Marie, Souhami, Luis

“…Abstract only 5008 Background: Long-term androgen deprivation therapy (ADT) combined with radiotherapy (RT) is a standard treatment for patients with high-risk…”
Get full text

A cosmetic evaluation of breast cancer treatment: a randomized study of radiotherapy boost technique by Vass, Sylvie, Bairati, Isabelle

“…To compare cosmetic results of two different radiotherapy (RT) boost techniques used in the treatment of breast cancer after whole breast radiotherapy and to…”
Get more information

Causes of death in intermediate- and high-risk prostate cancer treated with radiotherapy with or without androgen deprivation therapy: Analysis from two phase III trials by Nabid, Abdenour, Carrier, Nathalie, Vigneault, Eric, Martin, André-Guy, Souhami, Luis, Duclos, Marie, Bahary, Jean-Paul, Nguyen-Huynh, Thu-Van, Lemaire, Céline, Brassard, Marc-André, Vass, Sylvie, Bahoric, Boris, Archambault, Robert, Vincent, François

“…Abstract only 34 Background: The purpose of this analysis was to establish causes of death in a population of intermediate-risk (IR) and high-risk (HR)…”
Get full text

A Randomized Trial of Antioxidant Vitamins to Prevent Second Primary Cancers in Head and Neck Cancer Patients by Bairati, Isabelle, Meyer, François, Gélinas, Michel, Fortin, André, Nabid, Abdenour, Brochet, François, Mercier, Jean-Philippe, Têtu, Bernard, Harel, François, Mâsse, Benoît, Vigneault, Éric, Vass, Sylvie, del Vecchio, Pierre, Roy, Jean

“…Background: Although low dietary intakes of antioxidant vitamins and minerals have been associated with higher risks of cancer, results of trials testing…”
Get full text

Long-term quality of life in high-risk prostate cancer: Results of a phase III randomized trial by Nabid, Abdenour, Carrier, Nathalie, Martin, André-Guy, Bahary, Jean-Paul, Souhami, Luis, Duclos, Marie, Vincent, François, Vass, Sylvie, Bahoric, Boris, Archambault, Robert, Lemaire, Céline

“…Abstract only 5 Background: To evaluate long-term quality of life (QOL) in 630 patients with high-risk prostate cancer (HRPC) treated in a prospective…”
Get full text

Duration of androgen deprivation therapy in high-risk prostate cancer: A randomized trial by Nabid, Abdenour, Carrier, Nathalie, Martin, André-Guy, Bahary, Jean-Paul, Souhami, Luis, Duclos, Marie, Vincent, Francois, Vass, Sylvie, Bahoric, Boris, Archambault, Robert, Lemaire, Céline

“…Abstract only LBA4510 Background: Radiotherapy (RT) and long-term androgen deprivation therapy (ADT) is a standard treatment for patients with high-risk…”
Get full text

Duration of androgen deprivation therapy in high-risk prostate cancer: A randomized trial by Nabid, Abdenour, Carrier, Nathalie, Martin, André-Guy, Bahary, Jean-Paul, Souhami, Luis, Duclos, Marie, Vincent, Francois, Vass, Sylvie, Bahoric, Boris, Archambault, Robert, Lemaire, Céline

“…Abstract only LBA4510 The full, final text of this abstract will be available at abstract.asco.org at 7:30 AM (EDT) on Monday, June 3, 2013, and in the Annual…”
Get full text

High-risk prostate cancer treated with pelvic radiotherapy and 36 versus 18 months of androgen blockade: Results of a phase III randomized study by Nabid, Abdenour, Carrier, Nathalie, Martin, André-Guy, Bahary, Jean-Paul, Souhami, Luis, Duclos, Marie, Vincent, François, Vass, Sylvie, Bahoric, Boris, Archambault, Robert, Lemaire, Céline

“…Abstract only 3 Background: Radiotherapy (RT) and long term androgen blockade (AB) is standard treatment for patients with high risk prostate cancer. However,…”
Get full text